Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 18/20 | 0.66 |
| ▸ | IDH1 | O75874 | 2/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.51 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1972742 | 1.00 | HSD11B1 (0.66) | HSD11B1IDH1PDE4AHSD17B3PDE4B | |
| SCHEMBL2010766 | 0.85 | HSD11B1 (0.71) | HSD11B1IDH1PDE4AHSD17B3PDE4B | |
| SCHEMBL2012884 | 0.85 | HSD11B1 (0.71) | HSD11B1IDH1PDE4AHSD17B3PDE4B | |
| SCHEMBL3398864 | 0.84 | HSD11B1 (0.77) | HSD11B1IDH1 | |
| SCHEMBL12571453 | 0.82 | HSD11B1 (0.64) | HSD11B1IDH1PDE4AHSD17B3PDE4B | |
| SCHEMBL2004762 | 0.82 | HSD11B1 (0.66) | HSD11B1IDH1 | |
| SCHEMBL1968395 | 0.81 | HSD11B1 (0.68) | HSD11B1PDE4AHSD17B3PDE4BPDE4C | |
| SCHEMBL3404506 | 0.81 | HSD11B1 (0.62) | HSD11B1IDH1 | |
| SCHEMBL2005806 | 0.80 | HSD11B1 (0.57) | HSD11B1IDH1 | |
| SCHEMBL1973320 | 0.80 | HSD11B1 (0.57) | HSD11B1IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7964618-B2 | 2-[(3R)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanyl-pyridin-2-yl]-3-piperidyl]acetic acid, for example; compounds possess human 11- beta-hydroxysteroid dehydrogenase type1 enzyme (11 beta HSD1) inhibitory activity and accordingly have value in treatment of disease states including metabolic syndrome | ASTRAZENECA AB (SE) | 2011-06-21 | — | — | US | disclosed |